Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DIASORIN INC
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-10-01 to 2025-09-30
Current total value of award: $117505.1
Description: THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE THE FY26 OPTION YEAR AND TO DECREASE PRICING ON SUBCLINS 0001AG, 1001AA,2001AA, 3001AA AND 4001AA.